Annual report [Section 13 and 15(d), not S-K Item 405]

Equity Compensation - Schedule of Stock Option Activity (Details)

v3.25.4
Equity Compensation - Schedule of Stock Option Activity (Details) - USD ($)
12 Months Ended
Jan. 03, 2026
Dec. 28, 2024
Dec. 30, 2023
Stock Options      
Beginning balance outstanding (in shares) 676,585 719,525  
Granted (in shares) 0 0  
Exercised (in shares) 0 (2,069)  
Forfeited (in shares) (38,630) (40,871)  
Ending balance outstanding (in shares) 637,955 676,585 719,525
Outstanding, unvested (in shares) 160,024    
Vested not exercised (in shares) 477,931    
Weighted-Average Exercise Price, per share      
Beginning balance outstanding (in dollars per share) $ 9.4 $ 9.4  
Granted (in dollars per share) 0 0  
Exercised (in dollars per share) 0 0  
Forfeited (in dollars per share) 0 0  
Ending balance outstanding (in dollars per share) 9.4 9.4 $ 9.4
Vested and payable (in dollars per share) 9.4 9.4 $ 9.4
Vested not exercised (in dollars per share) $ 9.4 $ 9.40  
Weighted average remaining contractual life (in years) 6 years 4 months 24 days 7 years 4 months 24 days 8 years 4 months 24 days
Weighted average remaining contractual life, vested not exercised (in years) 6 years 4 months 24 days    
Aggregate intrinsic value $ 0 $ 0 $ 2,000,000.0
Unvested, intrinsic value 0    
Vested, aggregate intrinsic value $ 0